Evidence map›Paper›PMID 25261492›Full record

Trial reportThe Journal of infectious diseases2015

Acquisition and persistence of human papillomavirus 16 (HPV-16) and HPV-18 among men with high-HPV viral load infections in a circumcision trial in Kisumu, Kenya.

Virginia Senkomago, Danielle M Backes, Michael G Hudgens, Charles Poole, Kawango Agot, Stephen Moses, Peter J F Snijders, Chris J L M Meijer, Albertus T Hesselink, Nicolas F Schlecht and 2 more

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Journal of infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Male Circumcision Reduces Penile HPV Incidence and Persistence: A Randomized Controlled Trial in Kenya.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2021
    Trial
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 4 countries.

Virginia SenkomagoDepartment of Epidemiology.
Danielle M BackesDepartment of Epidemiology Department of Epidemiology, Brown Public Health, Brown University, Providence, Rhode Island.
Michael G HudgensDepartment of Biostatistics, Gillings School of Global Public Health.
Charles PooleDepartment of Epidemiology.
Kawango AgotImpact Research and Development Organization, Kisumu, Kenya.
Stephen MosesCentre for Global Public Health, University of Manitoba, Winnipeg, Canada.
Peter J F SnijdersDepartment of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
Chris J L M MeijerDepartment of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
Albertus T HesselinkDepartment of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
Nicolas F SchlechtDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, New York, New York.
Robert C BaileyDivision of Epidemiology and Biostatistics, School of Public Health, University of Illinois, Chicago.
Jennifer S SmithDepartment of Epidemiology Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill.
Amsterdam UMC Location VUmc · NLAlbert Einstein College of Medicine · USBrown University · USImpact Research and Development Organization · KEUNC Lineberger Comprehensive Cancer CenterUniversity of Illinois Urbana-Champaign · USUniversity of Manitoba · CA

Funding

Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Trial of Male Circumcision to Reduce HIV IncidenceU01AI050440 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BAILEY, ROBERT CONVERSE · 2001 to 2009
$14.7M
DevelopmentalP30AI082151 · NIAID · RUSH UNIVERSITY MEDICAL CENTER · PI LANDAY, ALAN L · 2009 to 2014
$4.6M
Effect of Male Circumcision on Penile HPV InfectionR01CA114773 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SMITH, JENNIFER SUSAN · 2005 to 2010
$2.1M
CIHRNCI NIH HHS R01 CA114773NCI NIH HHS R01 CA114773-04NIAID NIH HHS 5 P30 AI050410-13NIAID NIH HHS AI50440NIAID NIH HHS P30 AI050410NIAID NIH HHS P30 AI 082151NIAID NIH HHS P30 AI082151NIAID NIH HHS U01 AI050440
6 · The paper itself

Abstract

backgroundCircumcision and lower human papillomavirus (HPV) viral loads in men are possibly associated with a reduced risk of HPV transmission to women. However, the association between male circumcision and HPV viral load remains unclear.

methodsSwab specimens from the glans and shaft of the penis were collected from men enrolled in a circumcision trial in Kisumu, Kenya. GP5+/6+ polymerase chain reaction (PCR) was used to identify HPV DNA types. HPV-16 and HPV-18 loads were measured with a LightCycler real-time PCR and classified as high (>250 copies/scrape) or low (≤250 copies/scrape).

resultsA total of 1159 men were randomly assigned to undergo immediate circumcision, and 1140 men were randomly assigned to the control arm (these individuals were asked to remain uncircumcised until the study ended). The hazard of acquisition of high-viral load infections in the glans was lower in the circumcision arm, compared with the control arm, for HPV-16 (hazard ratio [HR], 0.32 [95% confidence interval {CI}, .20-.49]) and HPV-18 (HR, 0.34 [95% CI, .21-.54]). The 6-month risk of HPV persistence among men with high-viral load infections in the glans at baseline was lower in the circumcision arm, compared with the control arm, for HPV-16 (risk ratio [RR], 0.36 [95% CI, .18-.72]) and HPV-18 (RR 0.34 [95% CI, .13-.86]). Weaker and less precise results were obtained for shaft samples.

conclusionsMale circumcision could potentially reduce the risk of HPV transmission to women by reducing the hazard of acquisition, and the risk of persistence of high-HPV viral load infections in the glans in men.

Indexed as

Circumcision, MaleViral LoadAdolescentAdultFemaleHuman papillomavirus 16Human papillomavirus 18HumansKenyaMalePapillomavirus InfectionsPenisPolymerase Chain ReactionPrevalenceTreatment OutcomeYoung AdultHPV-16HPV-18human papillomavirus (HPV)Kenyamale circumcisionmenpersistencerandomized controlled trial (RCT), incidenceviral load

Identifiers

PMID25261492
PMCPMC4402376
OpenAlexW2095620089

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.